Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis

International Journal of Pediatric Otorhinolaryngology

Volumn 71, Issue 10, 2007, Pages 1501-1508

  Brook, Itzhak ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta lactamase; Cephalosporins; Group A Streptococci; Penicillin; Tonsillitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFDINIR; CEFDITOREN PIVOXIL; CEFIXIME; CEFPODOXIME; CEFTIBUTEN; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; LINCOMYCIN; LORACARBEF; MACROLIDE; PENICILLIN G; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; DRUG PENETRATION; DRUG SUBSTITUTION; HUMAN; MORAXELLA CATARRHALIS; PATIENT COMPLIANCE; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS GROUP A; TONSIL CELL; TONSILLITIS; TREATMENT FAILURE; TREATMENT INDICATION;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HUMANS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; PENICILLINS; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT FAILURE;

EID: 34548411300     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2007.06.006     Document Type: Review

References (55)

1. Pichichero M.E., and Casey J.R. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn. Microbiol. Infect. Dis. 57 Suppl. (2007) S39-S45
2. Kaplan E.L., Chatwal G.S., and Rohde M. Reduced ability of penicillin to eradicate ingested Group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin. Infect. Dis. 43 (2006) 1398-1406
3. Brook I. Role of beta-lactamase-producing bacteria in the persistence of strepharyngo-tonsillitisococcal tonsillar infection. Rev. Infect. Dis. 6 (1984) 601-607
4. Lafontaine E.R., Wall D., Vanlerberg S.L., Donabedian H., and Sledjeski D.D. Moraxella catarrhalis coaggregates with Strepharyngo-tonsillitisococcus pyogenes and modulates interactions of S pyogenes with human epithelial cells. Infect. Immun. 72 (2004) 6689-6693
5. Grahn E., and Holm S.E. Bacterial interference in the throat flora during a strepharyngo-tonsillitisococcal tonsillitis outbreak in an apartment house area. Zbl Bakl Hyg A 256 (1983) 72-79
6. Socransky S.S., and Manganiello S.D. The oral microflora of man from birth to Senility. J. Periodontol. 42 (1971) 485-496
7. Brook I., and Gillmore J.D. Enhancement of growth of Group A beta-hemolytic streptococci in mixed infections with aerobic and anaerobic bacteria. Clin. Microbiol. Infect. 1 (1996) 179-182
8. Tarsia P., Aliberti S., Pappalettera M., and Blasi F. Mixed community-acquired lower respiratory tract infections. Curr. Infect. Dis. Rep. 9 (2007) 14-20
9. Hagman M.M., Dale J.B., and Stevens D.L. Comparison of adherence to and penetration of a human laryngeal epithelial cell line by GABHS of various M protein types. FEMS Immunol. Med. Microbiol. 23 (1999) 195-204
10. Neeman R., Keller N., Barzilai A., Korenman Z., and Sela S. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352 (1998) 1974-1977
11. Stjernquist-Desatnik A., Samuelsson P., and Walder M. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J. Laryngol. Otol. 107 (1993) 309-312
12. Marouni M.J., Barzilai A., Keller N., Rubinstein E., and Sela S. Intracellular survival of persistent Group A streptococci in cultured epithelial cells. Int. J. Med. Microbiol. 294 (2004) 27-33
13. Orrling A., Kamme C., and Stjernquist-Desatnik A. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute Group A streptococcal pharyngotonsillitis. Scand. J. Infect. Dis. 37 (2005) 429-435
14. Brook I. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch. Otolaryngol. Head Neck Surg. 114 (1988) 667-670
15. Brook I., and Gober A.E. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin. Infect. Dis. 22 (1996) 143-145
16. Brook I., and Gober A.E. Emergence of beta-lactamase producing aerobic and aerobic bacteria in the oro-pharynx of children following penicillin chemotherapy. Clin. Pediatr. 23 (1984) 338-341
17. Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A strepharyngo-tonsillitisococci. Pediatr. Infect. Dis. 4 (1985) 491-495
18. Brook I., Yocum P., and Friedman E.M. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann. Otol. Rhinol. Laryngol. 90 (1981) 261-263
19. Reilly S., Timmis P., Beeden A.G., and Willis A.T. Possible role of the anaerobe in tonsillitis. J. Clin. Pathol. 34 (1981) 542-547
20. Tuner K., and Nord C.E. Beta-lactamase-producing anaerobic bacteria in recurrent tonsillitis. J. Antimicrob. Chemother. 10 Suppl. A (1982) 153-156
21. Chagollan J., Macias J.R., and Gil J.S. Flora indigena de las amigdales. Invest. Med. Int. 11 (1984) 36-39
22. Kielmovitch I.H., Keleti G., Bluestone C.D., Wald E.R., and Gonzales C. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch. Otolaryngol. Head Neck Surg. 115 (1989) 721-725
23. Brook I., Yocum P., and Foote Jr. P.A. Changes in the core tonsillar bacteriology of recurrent tonsillitis 1977-1993. Clin. Infect. Dis. 21 (1995) 171-176
24. Brook I., and Yocum P. Quantitative measurement of beta-lactamase level in tonsils of children with recurrent tonsillitis. Acta Otolaryngol. Scand. 98 (1984) 446-460
25. Brook I. Beta-lactamase-producing bacteria and their role in infection. Rev. Med. Microbiol. 16 (2005) 91-99
26. Brook I., and Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to Group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin. Pediatr. 24 (1985) 331-336
27. Brook I. Treatment of patients with acute recurrent tonsillitis due to Group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J. Antimicrob. Chemother. 24 (1989) 227-233
28. Kaplan E.L., and Johnson D.R. Eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J. Pediatr. 113 (1988) 400-403
29. Holm S., Henning C., Grahn E., Lomberg H., and Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand. J. Infect. Dis. 27 (1995) 221-228
30. Holm S.E., Roos K., and Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr. Infect. Dis. J. 10 (1991) S68-S71
31. Brook I., and Gober A.E. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A strepharyngo-tonsillitisococcal pharyngotonsillitis. Arch. Otolaryngol. Head Neck Surg. 121 (1995) 1405-1409
32. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol. Head Neck Surg. 133 (2005) 139-146
33. Brook I., and Gober A.E. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent Group A beta-hemolytic strepharyngo-tonsillitisococcal tonsillitis. Arch. Otolaryngol. Head Neck Surg. 125 (1999) 552-554
34. Roos K., Grahn E., Holm S.E., Johansson H., and Lind L. Interfering alpha-strepharyngo-tonsillitisococci as a protection against recurrent strepharyngo-tonsillitisococcal tonsillitis in children. Int. J. Pediatr. Otol. 25 (1993) 141-148
35. Roos K., Holm S.E., Grahn E., and Lind L. Alpha-strepharyngo-tonsillitisococci as supplementary treatment of recurrent strepharyngo-tonsillitisococcal tonsillitis: a randomized placebo-controlled study. Scand. J. Infect. Dis. 25 (1993) 31-35
36. Roos K., Holm S.E., Grahn-Hakansson E., and Lagergren L. Recolonization with selected alpha-strepharyngo-tonsillitisococci for prophylaxis of recurrent strepharyngo-tonsillitisococcal pharyngotonsillitis-a randomized placebo-controlled multicentre study. Scand. J. Infect. Dis. 28 (1996) 459-462
37. Falck G., Grahn-Håkansson E., Holm S.E., Roos K., and Lagergren L. Tolerance and efficacy of interfering alpha-strepharyngo-tonsillitisococci in recurrence of strepharyngo-tonsillitisococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol. (Stockh) 119 (1999) 944-948
38. Brook I., and Gober A.E. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J. Med. Microbiol. 54 (2005) 553-556
39. Brook I., and Gillmore J.D. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with Group A beta-hemolytic strepharyngo-tonsillitisococci. Antimicrob. Agents Chemother. 37 (1993) 1452-1455
40. Brook I. The role of anaerobic bacteria in tonsillitis. Int. J. Pediatr. Otorhinolaryngol. 69 (2005) 9-19
41. Brook I., and Gillmore J.D. Enhancement of growth of Group A beta-hemolytic strepharyngo-tonsillitisococci in mixed infections with aerobic and anaerobic bacteria. Clin. Microbiol. Infect. 1 (1996) 179-182
42. Brook I., and Gober A.E. Increased recovery of Moraxella catarrhalis and Haemophillus influenzae in association with Group A beta-hemolytic strepharyngo-tonsillitisococci in healthy children and those with pharyngo-tonsillitis. J. Med. Microb. 55 (2006) 989-992
43. Casey J.R., and Pichichero M.E. Meta-analysis of cephalosporins versus penicillin for treatment of Group A strepharyngo-tonsillitisococcal tonsillopharyngitis in adults. Clin. Infect. Dis. 38 (2004) 1526-1534
44. Pichichero M.E. Cephalosporins are superior to penicillin for treatment of strepharyngo-tonsillitisococcal tonsillopharyngitis: is the difference worth it?. Pediatr. Infect. Dis. J. 12 (1993) 268-274
45. Bisno A.L., Gerber M.A., Gwaltney Jr. J.M., Kaplan E.L., and Schwartz R.H. Practice guidelines for the diagnosis and management of Group A strepharyngo-tonsillitisococcal pharyngitis. Clin. Infect. Dis. 35 (2002) 113-125
46. Casey J.R., and Pichichero M.E. Meta-analysis of short course antibiotic treatment for Group a strepharyngo-tonsillitisococcal tonsillopharyngitis. Pediatr. Infect. Dis. J. 24 (2005) 909-917
47. Wellington K., and Curran M.P. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections. Drugs 64 (2004) 2597-2618
48. Brook I., and Foote P.A. Efficacy of penicillin versus cefdinir in eradication of Group A strepharyngo-tonsillitisococciand tonsillar flora. Antimicrob. Agents Chemother. 49 (2005) 4787-4788
49. Smith T.D., Huskins W.C., Kim K.S., and Kaplan E.L. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for Group A streptococcal pharyngitis. J. Pediatr. 110 (1987) 777-782
50. Rathore M.H., and Jenkins S.G. Group A beta-hemolytic strepharyngo-tonsillitisococcus: issue of resistance. Pediatr. Infect. Dis. J. 12 (1993) 354-355
51. Richter S.S., Heilmann K.P., Beekmann S.E., et al. Macrolide-resistant Strepharyngo-tonsillitisococcus pyogenes in the United States 2002-2003. Clin. Infect. Dis. 41 (2005) 599-608
52. Martin J.M., Green M., Barbadora K.A., and Wald E.R. Erythromycin-resistant Group A strepharyngo-tonsillitisococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346 (2002) 1200-1206
53. Tanz R., Shulman T., Sroka A., Marubio S., Brook I., and Yogev R. Lack of Influence of beta-lactamase-production flora on recovery of Group A strepharyngo-tonsillitisococci after treatment of acute pharyngitis. J. Pediatr. 117 (1990) 859-863
54. Brook I., and Gober A.E. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J. Antimicrob. Chemother. 41 (1998) 489-492
55. Tanz R.R., and Shulman S.T. Strepharyngo-tonsillitisococcal pharyngitis: the carrier state, definition, and management. Pediatr. Ann. 27 (1998) 281-285